. A consensus sequence in the endothelin-B receptor second intracellular loop is required for NHE3 activation by endothelin-1. Am J Physiol Renal Physiol 288: F732-F739, 2005. First published December 14, 2004; doi:10.1152/ajprenal. 00300.2004.-Endothelin-1 (ET-1) increases the activity of Na ϩ /H ϩ exchanger 3 (NHE3), the major proximal tubule apical membrane Na ϩ /H ϩ antiporter. This effect is seen in opossum kidney (OKP) cells expressing the endothelin-B (ET B) and not in cells expressing the endothelin-A (ET A) receptor. However, ET-1 causes similar patterns of protein tyrosine phosphorylation, adenylyl cyclase inhibition, and increases in cell [Ca 2ϩ ] in ETA-and ETB-expressing OKP cells, implying that an additional mechanism is required for NHE3 stimulation by the ET B receptor. The present studies used ETA and ETB receptor chimeras and site-directed mutagenesis to identify the ET receptor domains that mediate ET-1 regulation of NHE3 activity. We found that binding of ET-1 to the ET A receptor inhibits NHE3 activity, an effect for which the COOH-terminal tail is necessary and sufficient. ET-1 stimulation of NHE3 activity requires the COOHterminal tail and the second intracellular loop of the ET B receptor. Within the second intracellular loop, a consensus sequence was identified, KXXXVPKXXXV, that is required for ET-1 stimulation of NHE3 activity. This sequence suggests binding of a homodimeric protein that mediates NHE3 stimulation. opossum kidney cells; endothelin-A/endothelin-B chimeras; sodium/ hydrogen antiporter activity THE ENDOTHELINS (ET) are a family of three 21-amino acid peptides, ET-1, ET-2, and ET-3. They are involved in a variety of physiological responses, such as vascular smooth muscle cell contraction and dilation, development, and regulation of renal function (17, 35) . The biological effects of the ETs are mediated by two receptor subtypes, ET A and ET B (3, 13, 32, 34) . ET-1 and ET-2 bind the ET A receptor with high affinities, whereas ET-3 binds with low affinity. The three isopeptides bind the ET B receptor with similar high affinities. Both receptors have seven hydrophobic transmembrane domains, characteristic of G protein-coupled receptors. Human ET A and ET B receptors exhibit significant amino acid sequence identity (55% overall, 74% within the putative transmembrane helices) (33, 36) . Of the receptor subdomains, the extracellular NH 2 terminus and the intracellular COOH-terminal tail display the least sequence similarities, whereas the sequences in intracellular loops 2 and 3 are relatively similar. Despite their similarities, studies have demonstrated distinct roles for these intracellular loops in the human receptors. Human ET A and ET B selectively couple to G␣s and G␣i, respectively, with the second and third intracellular loops of human ET A involved in G␣s activation and the third intracellular loop of human ET B involved in G␣i activation (22).
THE ENDOTHELINS (ET) are a family of three 21-amino acid peptides, ET-1, ET-2, and ET-3. They are involved in a variety of physiological responses, such as vascular smooth muscle cell contraction and dilation, development, and regulation of renal function (17, 35) . The biological effects of the ETs are mediated by two receptor subtypes, ET A and ET B (3, 13, 32, 34) . ET-1 and ET-2 bind the ET A receptor with high affinities, whereas ET-3 binds with low affinity. The three isopeptides bind the ET B receptor with similar high affinities. Both receptors have seven hydrophobic transmembrane domains, characteristic of G protein-coupled receptors. Human ET A and ET B receptors exhibit significant amino acid sequence identity (55% overall, 74% within the putative transmembrane helices) (33, 36) . Of the receptor subdomains, the extracellular NH 2 terminus and the intracellular COOH-terminal tail display the least sequence similarities, whereas the sequences in intracellular loops 2 and 3 are relatively similar. Despite their similarities, studies have demonstrated distinct roles for these intracellular loops in the human receptors. Human ET A and ET B selectively couple to G␣s and G␣i, respectively, with the second and third intracellular loops of human ET A involved in G␣s activation and the third intracellular loop of human ET B involved in G␣i activation (22) .
ET-1 increases the activity of the proximal tubule apical membrane Na ϩ /H ϩ antiporter, which mediates the majority of proximal tubular NaCl and NaHCO 3 absorption (10, 12, 29, 30) . This proximal tubule apical membrane Na ϩ /H ϩ activity is mediated by NHE3 (1, 4) . OKP cells, an opossum kidney cell line with many proximal tubule characteristics, express NHE3 (2, 23, 24) . Using stable transfection, we established OKP cell lines expressing ET A and ET B receptors and showed that in cells expressing the ET B , but not the ET A receptor, ET-1 increases NHE3 activity (7) . In addition, NHE3 activation by ET-1 was inhibited by ET B receptor blockers, but not by ET A receptor blockers. Finally, in proximal tubules harvested from ET B receptor knockout mice, ET-1 fails to increase NHE3 activity, whereas stimulation is seen in tubules from wild-type mice (20) . These findings agree with immunohistochemistry and binding studies showing that the ET B receptor is the predominant ET receptor on the renal proximal tubule (9, 42) . However, the mechanism responsible for the receptor specificity of NHE3 regulation remains unclear. We previously showed that ET-1 causes similar patterns of protein tyrosine phosphorylation, adenylyl cyclase inhibition, and increases in cell [Ca 2ϩ ] in ET A -and ET B -expressing OKP cells, implying that an additional signaling pathway must mediate the receptor specificity of NHE3 regulation (7, 8, 28) .
To address this, in the current study human ET A /ET B receptor chimeras and site-directed mutagenesis were used to identify the ET receptor domain(s) involved in ET-1 regulation of NHE3 activity in OKP cells. We found that ET A receptor activation inhibits NHE3 activity, an effect for which the COOH-terminal tail is necessary and sufficient. Activation of NHE3 by ET-1 requires the COOH-terminal domain and the second intracellular loop of the ET B receptor. Site-directed mutagenesis within the ET B second intracellular loop identified residues critical for stimulation of NHE3 activity by ET-1. These residues define a consensus sequence, KXXXPKXXXV, required for ET-1 stimulation of NHE3. Cell culture and transfections. OKP cells were grown in DMEM supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 g/ml streptomycin at 37°C in a CO 2 incubator. To overexpress human ETA and ETB receptors, cells were transiently transfected with wild-type, chimera, or mutant receptors using the pME18S expression vector driven by a constitutively active SR␣ promoter (18) . OKP cells were plated on coverslips in 35-mm plastic dishes, grown to 80% confluence, transfected with 1.1 g DNA using Lipofectamine Plus according to the manufacturer's instructions, and grown to 100% confluence. Confluent cells were rendered quiescent by the removal of serum for 24 h before study. Cells on control and experimental coverslips were derived from the same flask and passage and were studied on the same day. ET A/ETB receptor chimeric cDNAs were generated as described (33) . Na ϩ /H ϩ antiporter activity. Cell pH was measured in a temperature-controlled spectrofluorometer (SLM 8000C, Rochester, NY) as the ratio of BCECF fluorescence with 500-and 450-nm excitation (emission wavelength 530 nm), as previously described (7, 8, 27, 28) . To measure Na ϩ /H ϩ antiporter activity, cells were acidified with nigericin and the initial rate of Na-dependent intracellular alkalinization was measured, as previously described (7, 8, 28) . In all studies, control and experimental cells were from the same passage and were assayed on the same day. Exposure to 10 Ϫ8 M ET-1 was begun at the time of BCECF loading (30 min before study). Control cells were exposed to the vehicle (0.1% acetic acid).
METHODS

Materials
Site-directed mutagenesis. Point mutations were generated using a Stratagene QuikChange Site-Directed Mutagenesis Kit (La Jolla, CA), as per kit protocol. Two primers complementary to each other were designed to contain the desired mutation ( Table 1 ). The plasmid containing the wild-type receptor was grown up in a dam ϩ Escherichia coli strain, resulting in the plasmid DNA methylation. Thermal cycling was performed as per kit instructions (12 cycles of 95°C ϫ 30 s, 55°C ϫ 1 min, and 68°C ϫ 1 min/kb plasmid length) to denature the template, anneal the mutagenic primers, and synthesize the mutation-containing DNA using high-fidelity PfuTurbo DNA polymerase. Dpn1, an endonuclease (target sequence: 5Ј-Gm 6 ATC-3Ј) specific for methylated and hemimethylated DNA, was used to digest the methylated, nonmutated parental DNA template. The circular mutated DNA was transformed into XL1-Blue supercompetent cells for nick repair and the DNA isolated by miniprep.
Binding experiments. To measure ET-1 binding, cells were grown to confluence in 12-well plates, rendered quiescent, and incubated in medium containing 0.3% BSA and 20 pM 125 I-ET-1, Ϯ10 Ϫ6 M cold ET-1 for 1 h at 37°C. After the binding solution was removed, the cells were washed twice with cold PBS, harvested in 0.5 ml of 1 N NaOH, placed in a scintillation cocktail, and bound ET-1 was counted in a Beckman LS3801 model scintillation counter (Fullerton, CA), as described (7) . Nonspecific binding was defined as binding that occurred in the presence of excess (10 Ϫ6 M) cold ET-1 and was subtracted from total binding (assayed in the absence of cold ET-1) to obtain specific binding. Results are expressed as a percentage of specific binding in cells transfected with the wild-type ET B receptor.
Statistics. Data are reported as means Ϯ SE. Statistical significance was determined using a paired Student's t-test (NHE3 activity studies) or ANOVA (binding studies) and set at P Ͻ 0.05.
RESULTS
We previously showed in stably transfected cells that the ET-1-induced increase in NHE3 activity is mediated by ET B and not ET A receptors. The first step of this study was to compare the effect of ET-1 on NHE3 activity in wild-type OKP cells and OKP cells transiently transfected with the ET B or ET A receptor cDNA. In wild-type untransfected cells, 10 Ϫ8 M ET-1 applied for 30 min caused a consistent small, but statistically insignificant, increase (ϩ15%) in NHE3 activity (Fig.  1) . When the ET B receptor was expressed, 10 Ϫ8 M ET-1 significantly increased NHE3 activity by 38%, in agreement with our previous study (7) . In contrast, in OKP cells expressing the ET A receptor, 10 Ϫ8 M ET-1 significantly inhibited NHE3 activity (Ϫ15%). Sense gga gta gaa tta aag ga att g gga ttc caa aat gga cag cag V841I Reverse ctg ctg tcc att ttg gaa tcc caa ttc ctt taa ttc tac tcc Mutant 4
Sense gga att ggg gtt cca aaa gtg aca gca gta gaa att gtt ttg K843L Reverse caa aac aat ttc tac tgc tgt cac ttt tgg aac ccc aat tcc Mutant 5 (Also X4) Sense gga att ggg gtt cca aaa gtg aca gca gta gaa att gtt ttg W844V Reverse caa aac aat ttc tac tgc tgt cac ttt tgg aac ccc aat tcc Mutant 6
Sense ggg gtt cca aaa tgg aca gca ata gaa att gtt ttg att tgg g V847I Reverse ccc aaa tca aaa caa ttt cta ttg ctg tcc att ttg gaa ccc c X1 Sense gga gta gaa tta aa gta a ttg ggg ttc caa aat gga cag c G838V Reverse gct gtc cat ttt gga acc cca att act tta att cta ctc c X2 Sense gga gta gaa tta aag ga gtt g ggg ttc caa aat gga cag c I839V Reverse gct gtc cat ttt gga acc cca act cct tta att cta ctc c X3 Sense gta gaa tta aag gaa tt gcg g ttc caa aat gga cag cag G840A Reverse ctg ctg tcc att ttg caa ccg caa ttc ctt taa ttc tac X5 Sense ggg gtt cca aaa tgg gca gca gta gaa att gtt ttg att tgg T845A Reverse cca att caa aac aat tcc tac tgc tgc cca ttt tgg aac ccc X6 Sense ggg gtt cca aaa tgg aca gta gta gaa att gtt ttg att tgg A846V Reverse cca aat caa aac aat ttc tac tac tgt cca ttt tgg aac ccc Delete Sense gct tct tgg agt aga att aaa ⌬ att ggg gtt cca aaa tgg aca gc G838 Reverse gct gtc cat ttt gga acc cca att tta att cta ctc caa gaa gc P842A Sense gga att ggg gtt gca aaa tgg aca gca gta gaa att g Reverse caa ttt cta ctg ctg tcc att ttg caa ccc caa ttc c To identify the domain(s) of the ET B and ET A receptors involved in ET-1 regulation of NHE3 activity, we transfected cells with chimeric ET A and ET B receptor cDNAs. Figure 2 shows the restriction sites used to generate the chimeric cDNAs. Nomenclature will indicate the specific domains derived from each receptor. For example, chimera A(N-III)B(IV-C) designates a chimeric receptor consisting of the ET A sequence from the NH 2 -terminal extracellular tail to the third transmembrane domain followed by the ET B sequence from the second intracellular loop through the COOH-terminal tail. To generate this chimera wild-type ET A and ET B receptor, cDNA was cut with BssHI ( By contrast, the above results using the chimera A(N-VII)B(C) suggest that the ET B COOH-terminal domain is not sufficient to mediate stimulation of NHE3 activity by ET-1. The failure of B(N-VII)A(C) to mediate ET-1-induced stimulation of NHE3 could indicate a requirement for the COOH terminus or could be due to ET A -induced inhibition mediated by the ET A COOH terminus. To determine whether the ET B COOH-terminal tail is required for ET-1 stimulation of NHE3, we examined a truncated ET B receptor in which the COOHterminal tail was removed (18) . As shown in Fig. 3 , with removal of the COOH-terminal tail ET-1 was without effect on NHE3 activity. Taken together, these results suggest that the ET B COOH-terminal tail is necessary but not sufficient to mediate stimulation of NHE3 activity by ET-1.
Role of the ET B receptor intracellular loops. To identify other key domains of the ET B receptor required for ET-1 stimulation of NHE3 activity, we used a series of chimeras in which domains of the ET B receptor were replaced with the corresponding region of the ET A receptor. As shown in Fig. 4 , when the ET B sequence extended from the COOH terminus to the third intracellular loop, [A(N-V)B(VI-C) and A(N-IV)B(V-C)], ET-1 had no effect on NHE3 activity. By contrast, when the second intracellular loop of the ET B receptor was included [A(N-III)B(IV-C)], ET-1 stimulation of NHE3 activity was restored (ϩ35%). These results suggest that in addition to the COOH-terminal tail, a specific region including transmem- 
. Endothelin (ET)A and ETB receptor regulation of Na
ϩ /H ϩ exchanger 3 (NHE3) activity. Opossum kidney (OKP) cells were grown, transfected, and exposed to 10 Ϫ8 M ET-1 or vehicle, and NHE3 activity was assayed as described in METHODS. Left: untransfected cells, n ϭ 8. Middle: ETB receptor sequence, n ϭ 18. Right: ETA receptor sequence, n ϭ 10. *P Ͻ 0.01. Fig. 2 . Schematic diagram showing the location of the restriction sites used to generate the chimeric cDNAs. The number of circles is based on the human ETA sequence. Dotted circles are sequence gaps placed in the sequence to align the ETA and ETB sequences. F Represent amino acid residues that are identical between the aligned human ETA and ETB sequences; E represent nonidentical residues. Positions of the restriction sites used to construct the chimeric receptors are shown by arrows along with the name of the restriction enzymes. TMD, transmembrane domain. Fig. 3 . Role of the COOH-terminal tail. Cells were grown, treated, and assayed as in Fig. 1 . A(N-VII)B(C) and B(N-VII)A(C) were generated and the COOH-terminal tail was removed in construct B(N-VII) using the restriction enzyme EcoRI (Fig. 2) . Blue, ETB receptor sequence. Red, ETA receptor sequence. ETA: n ϭ 3; A(N-VII)B(C): n ϭ 7; B(N-VII)A(C): n ϭ 7; B(N-VII): n ϭ 4. *P Ͻ 0.01. **P ϭ 0.057. brane helix III and/or the second intracellular loop of the ET B receptor is required for ET-1 stimulation of NHE3 activity.
To confirm this, an additional series of chimeras were used ( To further confirm this conclusion, we used a chimera in which both the second intracellular loop and COOH-terminal tail were derived from the ET B receptor and all other intracellular sequences were from the ET A receptor [A(N-III)B(IV-V)A(VI-VII)B(C)]. As shown in Fig. 5 , in cells expressing this chimera ET-1 increased NHE3 activity by 35%, confirming that the second intracellular loop and COOH-terminal tail of ET B are both required and sufficient for ET-1 stimulation of NHE3 activity.
Amino acid residues in the ET B receptor second intracellular loop required for ET-1 stimulation of NHE3 activity. The above studies all confirmed a key role for the domain including the second intracellular loop and transmembrane helix IV in NHE3 stimulation. We reasoned that the key domain was most likely intracellular and further pursued the second intracellular loop. The second intracellular loop is highly conserved with only six amino acids that differ between the ET A and ET B receptors (Fig. 6) . The specific role of each of these amino acids was analyzed by site-directed mutagenesis converting each of the six ET B amino acids individually to their corresponding ET A receptor amino acid (Fig. 6 and Table 1 ). As shown in Fig. 7 , respectively), the ET B receptor lost its ability to mediate ET-1 stimulation of NHE3 activity (Fig. 7) . Thus ET B Fig. 5 . Critical TMDs of the ETB receptor. Cells were grown, treated, and assayed as in Fig. 1 
. B(N-III)A(IV-VI)B(VII-C), B(N-IV)A(V-VI)B(VII-C), and A(N-III)B(IV-V)A(VI-VII)B(C)
were generated by using restriction enzymes BssHI/ClaI, NcoI/ClaI, and BssHI/BglII/EcoRI, respectively (Fig. 2) . Blue, ETB receptor sequence. Red, ETA receptor sequence. ETB: n ϭ 10;
B(N-III)A(IV-VI)B(VII-C): n ϭ 7; B(N-IV)A(V-VI)B(VII-C): n ϭ 6; A(N-III)B(IV-V)A(VI-VII)B(C)
: n ϭ 5. *P Ͻ 0.01. 
. A(N-V)B(VI-C), A(N-IV)B(V-C), and A(N-III)B(IV-C)
were generated using restriction enzymes BglII, NcoI, and BssHI, respectively ( ) lying between the two "K-V" pairs ( Fig. 6 and Table 1 ). W 844 is one of the 6 amino acid residues that differs between the ET B and ET A receptors. Mutation of this residue (W844V) had already been shown to have no effect on the ability of ET-1 to stimulate NHE3 activity (Fig. 7) . The other five potential X residues were replaced with either a valine or alanine residue. As shown in Fig. 8 , individually mutating these residues had no effect on the ability of ET-1 to stimulate NHE3 activity (% stimulation varied between 27 and 52%, P Ͻ 0.05 in all 6 experiments). However, removal of one of the X residues, G 838 , prevented the ET-1 effect (Fig. 9) . Thus, while the specific amino acids separating the K and V residues are not critical, the number of amino acids is important.
The two KXXXV sequences in the second intracellular loop are separated by a proline that is conserved in ET B and ET A receptors. Mutation of this proline residue (P 842 ) to alanine also prevented ET-1 from stimulating NHE3 activity (Fig. 9) . Taken together, these data suggest the presence of a consensus sequence (KXXXVPKXXXV) in the ET B receptor second intracellular loop that mediates ET-1 stimulation of NHE3 activity.
ET-1 binding to receptors. To address the possibility that the varying effect of ET-1 on NHE3 activity in the above studies was a consequence of a difference in receptor expression and/or failure of ET-1 to bind to a mutated receptor, ligand binding studies were performed in wild-type OKP cells and OKP cells expressing intact, and key truncated, chimeric, or mutated receptors in which ET-1 did not stimulate NHE3 activity ( Table 2) . As shown, specific ET-1 binding was not statistically different between cells expressing the wild-type ET B receptor and those expressing key truncated, chimeric, or mutated receptors.
DISCUSSION
The ETs are a family of three conserved 21 amino acid peptides that bind to and mediate their effects through two G protein-coupled receptor subtypes, ET A and ET B (3, 13, 32) . Despite significant amino acid homology, the receptors can be pharmacologically distinguished by their affinity for the three ET isopeptides and their distinct physiological roles (22, 26, 36) . The ET B receptor mediates release of relaxing factors causing vasodilation and is involved in inflammatory pain, whereas the ET A receptor mediates vasoconstriction, stimulates mitogenesis and matrix formation, is antiapoptotic, and is involved in acute or neuropathic pain (26) . Typically, the ET B receptor activates G␣i, whereas the ET A receptor activates G␣s, but this G protein coupling is not fixed in all cells (22, 36) . In the kidney, while both ET A and ET B are present in renal vessels and on tubular epithelial cells, ET B expression predominates in tubular epithelial cells (17, 31, 37) .
We previously showed that ET-1 stimulates NHE3 activity in cultured OKP cells, an effect that is mediated through the ET B and not the ET A receptor (7, 19) . ET-1/ET B stimulation of NHE3 activity involves NHE3 phosphorylation and exocytic insertion of NHE3 into the apical membrane (27, 28) . As shown in Fig. 1 , ET-1/ET A signaling not only fails to stimulate NHE3 activity but inhibits the transporter. The physiological significance of NHE3 inhibition is unclear as ET-1 stimulates the proximal tubule Na ϩ /H ϩ antiporter, an effect mediated by the ET B receptor (19, 20) .
Because of these differing effects on NHE3, we initially sought to determine signaling pathways that were differentially activated by the ET B and ET A receptors in OKP cells. Using inhibitors, we found that NHE3 activation by the ET B receptor was mediated by increases in cell Ca 2ϩ and activation of Ca 2ϩ -calmodulin kinase and tyrosine kinases. On ET-1 addition, both receptors were found to increase cell Ca 2ϩ with patterns that were indistinguishable. In addition, activation of Fig. 8 . Role of conserved residues in the proposed consensus sequence. Cells were grown, treated, and assayed as in Fig. 1 . Five amino acid residues lying between the 2 K-V pairs were individually mutated. Mutations were made as indicated in Table 1 . ETB: n ϭ 8; G838V: n ϭ 12; I839V: n ϭ 8; G840A: n ϭ 7; T845A: n ϭ 8; A846V: n ϭ 13. *P Ͻ 0.02. Fig. 7 . Role of amino acid residues in the second intracellular loop that differ between the ETA and ETB receptors. Cells were grown, treated, and assayed as in Fig. 1 . Mutations were made as indicated in Table 1 . ETB: n ϭ 21; I836V: n ϭ 7; K837Q: n ϭ 9; V841I: n ϭ 9; K843L: n ϭ 10; W844V: n ϭ 11; V847I: n ϭ 8. *P Ͻ 0.01. both receptors resulted in tyrosine phosphorylation of proteins with a pattern consistent with focal adhesion protein phosphorylation. Finally, although activation of ET A and ET B receptors can have opposing effects on adenylyl cyclase in many cells, in OKP cells both receptors inhibited adenylyl cyclase (7, 28) . These findings led us to hypothesize that an additional signaling pathway must be required for ET B receptor activation of NHE3, perhaps a protein that binds selectively to the ET B receptor. To address this, the present studies were designed to define domains unique to the ET B receptor that were required for NHE3 activation.
The ET A and ET B receptors exhibit 55% overall amino acid homology (22, 36) . Within the receptor domains, the least homology is seen in the intracellular COOH-terminal domain and the most homology is associated with the transmembrane helices. In addition, intracellular loops, a likely site of protein binding, are highly homologous. In the present studies, OKP cells were transiently transfected with human ET A and ET B receptor chimera as well as mutated ET B receptor cDNAs to determine the domains and sequences responsible for ET-1/ ET B stimulation of NHE3. Our laboratory previously showed that we achieve ϳ80% transfection efficiency with transient transfection in OKP cells (14) . In addition, we completely inhibited a number of cellular processes in cells transiently transfected with dominant-negative constructs, again suggesting high transfection efficiency (21, 39, 40) .
The studies led to a number of conclusions. First, the COOH-terminal tail of the ET A receptor is necessary and sufficient for inhibition of the NHE3 activity by ET-1. Thus a chimeric receptor that contains only the COOH-terminal tail of ET A , with the remainder of the receptor derived from the ET B receptor, inhibits NHE3. Similarly, an ET A receptor in which the COOH-terminal domain has been replaced with the relevant ET B sequence loses the ability to inhibit NHE3 activity.
Second, the COOH-terminal tail of ET B is required for stimulation of NHE3. Deletion of this sequence eliminates regulation, and replacement with the corresponding ET A sequence leads to ET-1-induced inhibition of NHE3 activity. However, unlike results with the ET A receptor, the COOHterminal tail is not sufficient for stimulation of NHE3. The chimera containing the COOH-terminal ET B sequence with the remainder of the protein derived from the ET A receptor fails to regulate NHE3 activity. This suggests that in addition to the COOH-terminal tail, at least one other sequence is required for NHE3 activation by ET-1/ET B .
The role of the COOH-terminal tail of G protein-coupled receptors has not been studied extensively. In the parathyroid Ca 2ϩ -sensing receptor, individual point mutations of His 880 and Phe 882 in the COOH-terminal tail to alanine residues were associated with decreased total inositol phosphate production and retention of the receptors in the endoplasmic reticulum, suggesting that the COOH-terminal tail is required for efficient targeting of the receptor to the cell surface (6) . In the present studies, however, absence of the ET B COOH-terminal tail did not decrease ET-1 binding, demonstrating that trafficking to the plasma membrane had not been impaired.
In addition to a requirement for the COOH-terminal tail, NHE3 activation by ET-1/ET B required a sequence within the second intracellular loop. Comparing a series of chimeras, results consistently demonstrated that the presence of sequences in the second intracellular loop and transmembrane domain IV, between the BssHI and NcoI restriction sites, was required for NHE3 activation. Mutational studies localized the key sequences to the second intracellular loop and further defined the specific sequence required: two essential lysine (K) and two essential valine (V) resides that are spaced as follows: KXXXVPKXXXV (Fig. 6 ). Both the spacing between the lysine and valine residues and the proline (P) residue were found to be essential to confer ET-1 stimulation of NHE3. The presence of the repeat sequence (KXXXV) and the space requirement for three residues between the K and V pairs Fig. 9 . G838 deletion and P842A mutation. Cells were grown, treated, and assayed as in Fig. 1 . Mutations were made as indicated in Table 1 . G838 deletion: n ϭ 6; P842A: n ϭ 9.
Table 2. ET-1 binding to receptors
Values are means Ϯ SE. Cells were grown and treated as in Fig. 1 . Ligand binding was assayed as described in METHODS. Wild-type opossum kidney cells: n ϭ 9; endothelin (ET)B cells: n ϭ 6; ETA cells: n ϭ 6; ETB minus C-tail; n ϭ 6; A(N-V)B(VI-C): n ϭ 3; B(N-III)A(IV-VI)B(VII-C): n ϭ 3; K837Q: n ϭ 3; V841I: n ϭ 6; K843L: n ϭ 6; V847I: n ϭ 6; Delete G838: n ϭ 3.
suggest that this portion of the receptor may be involved in the binding of a homodimer to the receptor. The presence of the proline residue, typically associated with flexibility in a protein, between the two repeat sequences would also facilitate binding of a homodimer.
The second and/or third intracellular loops have been shown to be critical for signaling in other G protein-coupled receptors. The second intracellular loop of the thrombin receptor confers specificity to Gq coupling, is hypothesized to be the relevant domain involved in G protein coupling and to mediate conformational changes that prevent or promote G protein coupling in the muscarinic receptor, and is critical for activating the phospholipase C (PLC) pathway through the Gq ␣-subunit in the PTH/PTH-related protein signaling pathway (5, 15, 25, 41) . The second and third intracellular loops are involved in inhibiting angiotensin-dependent activation of PLC via the angiotensin 1a receptor (38) . The second intracellular loop of the metabotropic glutamate receptor 1 is critical for signal transduction, but unlike most other G protein-coupled receptors, requires cooperation with another intracellular domain (11) . In Chinese hamster ovary cells expressing ET A /ET B receptor chimeric proteins, intracellular loops 2 and/or 3 of the ET A receptor mediate ET-1-induced stimulation of cAMP formation, whereas intracellular loop 3 of the ET B receptor mediates ET-1-induced inhibition of cAMP formation, demonstrating that intracellular loops 2 and 3 direct signaling through G␣s and G␣i, respectively (36) . Thus it appears that the intracellular loops of G protein-coupled receptors mediate signal transduction. In the present studies, we show that intracellular loop 2 of the ET B receptor mediates ET-1 stimulation of NHE3 activity.
The lack of an effect on ET-1 binding to the chimeric and mutated receptors is consistent with studies in COS-7 cells (33) . Similarly, the lack of an effect on ET-1 binding with removal of the ET B COOH-terminal tail is consistent with studies from Sakamoto et al. (18) showing that the COOHterminal tail of the ET B receptor is involved with signaling but not ligand binding. These observations suggest that the tertiary structure of the ET B receptor has been maintained in the chimeric and mutated receptors and that failure of ET-1 to stimulate NHE3 activity is not due to failure of the chimeric or mutated receptors to be expressed on the apical membrane.
In many of the studies in which cells were transfected with either the ET A receptor or one of the inactive receptors, baseline NHE3 activity was observed to be increased, compared with cells transfected with the ET B receptor or a functional receptor. One possible explanation for this observation is that the vacant ET A receptor stimulates NHE3 activity and/or the vacant ET B receptor inhibits NHE3 activity, both effects due to binding of a NHE3-regulatory protein. Binding of ET-1 to these receptors could then inhibit binding of the regulatory protein, relieving NHE3 regulation. Thus binding of ET-1 to the ET B receptor may prevent NHE3 inhibition and/or binding of ET-1 to the ET A receptor may prevent NHE3 stimulation by the vacant receptor.
Receptors have two functions, ligand recognition and binding ("address" function) and signal transmission ("message" function). Ligand binding studies have proposed that the region of transmembrane helices IV-VI and the adjacent loops of the ET A and ET B receptors determine the selection of ligandreceptor interaction and thus are considered to be the address recognition subdomain (33) . In the case of the ET A receptor, this region matches more closely to the NH 2 terminus (address domain) of ET-1 compared with ET-3, and thus ET A binds ET-1 with higher affinity than ET-3 (33) . Subtle differences in the ET B receptor allow the address recognition domain to interact with a wider spectrum of ligand address domains, making the ET B receptor more promiscuous (33) . The COOHterminal portion of the ligand interacts with transmembrane helices I, II, III, and VII of the ET A and ET B receptors to transmit the ligand message (22) . The present studies demonstrate that the amino acid sequence in the second intracellular loop and first part of transmembrane helix IV transmit the signal mediating ET-1 stimulation of NHE3 activity. The combination of a required repeat sequence, required spacing between essential amino acid residues, and a required proline residue between the repeat sequences suggests that the protein that binds the receptor might have symmetrical "arms" that interact with the receptor. Such a protein could be either a single protein or a homodimer.
In summary, the present studies identify the COOH-terminal tail and a sequence within the second intracellular loop of the ET B receptor that are necessary and sufficient to mediate ET-1 stimulation of NHE3 activity. The presence of a repeat sequence with specific space requirements and a required proline residue separating the repeat sequences suggests that signal transmission is mediated by the binding of a homodimeric protein to the receptor.
